The active ingredient aducanumab, which was discovered at the University of Zurich, has been approved for use in the United States as a treatment for Alzheimer’s disease.
University Operations in the Current and Upcoming Semester
The current semester will be completed with no changes to teaching and examinations. For the coming Fall Semester, UZH intends to return to teaching without restrictions. Further, the requirement to work from home will be lifted at UZH from 23 August 2021. The conditions for a possible phased implementation of on-site operations are currently in planning.
